International, Peer Reviewed, Open Access Journal

American Journal of Gastroenterology and Hepatology
(ISSN: 2692-7942)

Submit Manuscript

American Journal of Gastroenterology and Hepatology

American Journal of Gastroenterology and Hepatology (ISSN 2692-7942) follows double blind peer-review process under the guidance of our honorary editorial board members and external peers to maintain the publication standards and quality in the published articles.

Journal Features

Open Access

All the articles will be published under Open Access model.

Peer Review

Our editorial team performs strict peer-review process.

Publication Ethics

The journal follows standard guidelines to maintain transparency.

Submit Manuscript

The journal accepts all original articles, reviews and more.

About the Journal

American Journal of Gastroenterology and Hepatology (ISSN 2692-7942) is an open access, online, international, peer-reviewed journal which publishes original information in the form of research, reviews, case reports, short communications, etc. in the fields of Gastroenterology and Hepatology.

Open Access - American Journal of Gastroenterology and Hepatology

Editorial Board

Toru Ishikawa - American Journal of Gastroenterology and Hepatology
Editor-in-Chief

Toru Ishikawa

Department of Gastroenterology, Saiseikai Niigata Hospital
Japan

Hirotada Akiho - American Journal of Gastroenterology and Hepatology

Hirotada Akiho

Kitakyushu Municipal Medical Center
Japan

Jun Liu - American Journal of Gastroenterology and Hepatology

Jun Liu

Shandong University
China

Jose M Mato - American Journal of Gastroenterology and Hepatology

Jose M Mato

Spanish National Research Council
Spain

Yu-Fei Jiao - American Journal of Gastroenterology and Hepatology

Yu-Fei Jiao

The Second affiliated hospital of Harbin Medical University
China

Changqing Yang - American Journal of Gastroenterology and Hepatology

Changqing Yang

Tongji University School of Medicine
China

Giuseppe Scalabrino - American Journal of Gastroenterology and Hepatology

Giuseppe Scalabrino

University of Milan
Italy

Hayrettin Okut - American Journal of Gastroenterology and Hepatology

Hayrettin Okut

University of Kansas School of Medicine
United States

Alpha Ibrahima Balde - American Journal of Gastroenterology and Hepatology

Alpha Ibrahima Balde

Chairman of Chinese WAMS
Netherlands

Hongbing Zhang - American Journal of Gastroenterology and Hepatology

Hongbing Zhang

Chinese Academy of Medical Sciences
China

Chiao-Fang Teng - American Journal of Gastroenterology and Hepatology

Chiao-Fang Teng

China Medical University
Taiwan

Tsvetelina Velikova - American Journal of Gastroenterology and Hepatology

Tsvetelina Velikova

Lozenetz University Hospital
Bulgaria

Articles

Am J Gastroenterol Hepatol. 2021;2(1):AJGH-02-1008 | Open Access

Post-COVID-19 GI Manifestations: Are We in for the “Long Haul”?

Kevin V Houston, Byung-Soo Yoo, Steve M D’Souza, James Lau, Alsiddig Elmahdi, Parth J Parekh and David Johnson

Post-COVID-19 Gastrointestinal (GI) disease management remains a clinical challenge as the medical literature continues to evolve and expand. Reports of excess GI disease burden across the population, as well as prescribed use of pharmaceuticals for symptom relief, have proven “long-haul” GI disease is prevalent across the population. This article will help to summarize the current medical literature as ... Read more

REVIEW ARTICLE Updated Aug 20, 2021   PDF

Am J Gastroenterol Hepatol. 2020;1(2):ajgh-01-1007 | Open Access

Management of Oral Functioning in Tube-Fed Infants: New Considerations Regarding Tube Feeding at Birth and the Prevention of Food Refusal

Catherine Senez

In pediatrics, since 1970, tube feeding has been a huge step forward by improving the survival of neonates exhibiting malformations or medical problems. After medical or surgical repair, resumption of oral feeding is difficult if not impossible for some. They become dependent on the tube even when it is no longer useful. Furthermore, upon returning home, continued tube feeding leads to ... Read more

REVIEW ARTICLE Updated Nov 27, 2020   PDF

Am J Gastroenterol Hepatol. 2020;1(1):AJGH-01-1006 | Open Access

Real-Life Ustekinumab Response and Blood Cytokine Profiles in Patients with Crohn’s Disease

Lucas Schulte, Annika Beck, Johannes Hofelich, Hanna-Sophie Reuther and Jochen Klaus

Background: Crohn’s Disease (CD) is a chronic inflammatory bowel disease with strong impact on morbidity and quality of life. Ustekinumab (UST) has been shown to be an efficient agent for bionaive and patients with treatment failure of anti-TNF-alpha drugs in randomized controlled trials, but real-life efficacy and safety has still to be evaluated. Furthermore, due to ... Read more

RESEARCH ARTICLE Updated Oct 09, 2020   PDF

Am J Gastroenterol Hepatol. 2020;1(1):AJGH-01-1005 | Open Access

Laparoscopic Management of Intestinal Duplication Cyst in Children

Son TN* and Hoan VX

Purpose: To investigate the feasibility, safety and efficacy of Laparoscopic Surgery (LS) in management of Intestinal Duplication Cyst (IDC) in children.
Methods: Medical records of all patients with diagnosis IDC undergoing LS at our center from March, 2009 to October, 2012 were reviewed. Two types of laparoscopic procedures were performed: Completely Laparoscopic (CL) when the entire operation ... Read more

RESEARCH ARTICLE Updated May 05, 2020   PDF

Am J Gastroenterol Hepatol. 2020;1(1):AJGH-01-1004 | Open Access

Sofosbuvi, Daclatasvir, Simprevir and Ribavirin as a Re-Treatment Approach in HCV Patients Genotype 4, Egyptian Study

Wael M Abd El Ghany, ReemYehia and Hala I Mohamed

Background: Chronic HCV in whom prior DAA treatment had failed, outcomes after retreatment are optimal. Combination of SOF, DCV, SIM, and Ribavirin in treatment experienced patients, as recommended in current guidelines despite scarce data.
Aim: To determine the efficacy and safety of SOF, DCV, SIM plus RBV in Egyptian patients infected with chronic HCV GT4 ... Read more

RESEARCH ARTICLE Updated Feb 22, 2020   PDF